cbdMD, Inc. (YCBD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for cbdMD, Inc. (YCBD:NYSE), powered by AI.

Current Price
$0.69
P/E Ratio
-1.4
Market Cap
3M
Sector
Healthcare
What is the cbdMD, Inc. stock price forecast?

cbdMD, Inc. is currently trading at $0.69. View real-time AI analysis on Alpha Lenz.

What is cbdMD, Inc. insider trading activity?

View the latest insider trading data for cbdMD, Inc. on Alpha Lenz.

What is cbdMD, Inc.'s P/E ratio?

cbdMD, Inc.'s P/E ratio is -1.4.

cbdMD, Inc.

NYSE · YCBD
$0.69-0.01(-1.73%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about cbdMD, Inc.'s future dividend policy...
Alpha Chat Insight

cbdMD, Inc. trades at a P/E of -1.4 (undervalued) with modest ROE of -44.4%.

Ask for details

Company Overview

cbdMD, Inc. is a prominent player in the cannabidiol (CBD) industry, focusing on the production and distribution of high-quality, hemp-derived CBD products. The company's main purpose is to develop a diverse range of wellness products, which include tinctures, gummies, topicals, and bath bombs, designed to enhance personal health and wellness. cbdMD stands out in the competitive CBD market by prioritizing quality and purity, utilizing industry-leading manufacturing processes and rigorous third-party testing to ensure its products are THC-free and meet stringent standards. With its headquarters in Charlotte, North Carolina, cbdMD has positioned itself as a key contributor to the rapidly growing cannabis and wellness sectors. It serves both retail and wholesale clients across various channels, including e-commerce platforms, specialty health stores, and professional sports organizations. By leveraging strategic marketing and product innovation, cbdMD, Inc. continues to play a critical role in educating consumers and expanding the acceptance of CBD as a viable health supplement.

CEOMr. T. Ronan Kennedy
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees42

Company Statistics

FY 2025

Profile

$2.76MMarket Cap
$19.19MRevenue
0.00Shares Out
42Employees

Margins

62.37%Gross
-1.91%EBITDA
-11.27%Operating
-10.63%Pre-Tax
-10.63%Net

Valuation

-1.35P/E
0.38P/B
0.14EV/Sales
-3.48EV/EBITDA
-1.69P/FCF

Growth (CAGR)

-18.46%Rev 3Yr
-14.45%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-19.44%ROA
-44.42%ROE
-20.59%ROIC

Financial Health

$2.26MCash & Cash Equivalents
$932.60KNet Debt
44.20%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

cbdMD, Inc. (ticker: YCBD) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 42 employees. Market cap is $3M.

The current price is $0.686 with a P/E ratio of -1.35x and P/B of 0.38x.

ROE is -44.42% and operating margin is -11.27%. Annual revenue is $19M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
cbdMD, Inc. (YCBD) Stock Forecast 2026 $0.69 — Price, Financials & Analyst Targets | Alpha Lenz